Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05052268 · ClinicalTrials.gov registry record · Phase 1

XTX202 in Patients With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by Xilio Development.

Completed
Registry status
Phase 1
Development phase
95
Enrollment target
15
Study locations

NCT05052268 is a Phase 1 study of Advanced Solid Tumor that has completed, run by Xilio Development. The registered enrollment target is 95 participants, below the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (51% lower). The trial reports 15 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05052268, a Phase 1 study of Advanced Solid Tumor, has completed, sponsored by Xilio Development.

COMPLETED
Registry status
Phase 1
Development phase
95 participants
Enrollment target
15
Study locations

Study Summary

A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX202 in Patients with Advanced Solid Tumors

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG XTX202

Study Locations (15)

California

  • UC San Diego Moores Cancer Center - La Jolla
  • Norris Comprehensive Cancer Center - Los Angeles
  • University of California Los Angeles - Los Angeles
  • Hoag Memorial Hospital Presbyterian- Newport Beach - Newport Beach

New Jersey

  • Atlantic Health System/Morristown Medical Center - Morristown
  • Rutgers Cancer Institute of NJ - New Brunswick

District of Columbia

  • Georgetown University Medical Center - Washington D.C.

Florida

  • Moffitt Cancer Center - Tampa

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • HealthPartners Cancer Center at Regions Hospital - Saint Paul

North Carolina

  • Carolina BioOncology Institute - Huntersville

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2022-01-18
Est. Completion 2025-03-25
Phase Phase 1

Sponsor

Xilio Development

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05052268

The ClinicalTrials.gov registry entry for NCT05052268 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 192-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (51% lower). The listed sponsor is Xilio Development, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which XTX202 is the first listed.

NCT05052268 reports 15 study locations spanning 11 distinct geographic areas - top geographies include California, New Jersey, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05052268 about?

NCT05052268 is a clinical study titled "XTX202 in Patients With Advanced Solid Tumors". A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX202 in Patients with Advanced Solid Tumors

What is the current status of trial NCT05052268?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 95 participants. The study started on 2022-01-18. Estimated completion is 2025-03-25.

What conditions does trial NCT05052268 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT05052268?

The interventions under investigation include: XTX202 (DRUG).

Who is sponsoring clinical trial NCT05052268?

This trial is sponsored by Xilio Development, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05052268 being conducted?

This trial has 15 study locations across California, District of Columbia, Florida, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.